EMA approval · 2016-01-29

First specific replacement therapy to treat rare bleeding disorder

EMA announces the first specific replacement therapy for a rare bleeding disorder, marking a pivotal advancement in treatment options.

Upgrade for the full analysis, importance score, and drug timeline.